These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32769144)

  • 1. Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.
    Midgley AC; Wei Y; Zhu D; Gao F; Yan H; Khalique A; Luo W; Jiang H; Liu X; Guo J; Zhang C; Feng G; Wang K; Bai X; Ning W; Yang C; Zhao Q; Kong D
    J Am Soc Nephrol; 2020 Oct; 31(10):2292-2311. PubMed ID: 32769144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.
    Gupta S; Fink MK; Ghosh A; Tripathi R; Sinha PR; Sharma A; Hesemann NP; Chaurasia SS; Giuliano EA; Mohan RR
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1045-1057. PubMed ID: 29490341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte Growth Factor-Secreting Mesothelial Cell Sheets Suppress Progressive Fibrosis in a Rat Model of CKD.
    Oka M; Sekiya S; Sakiyama R; Shimizu T; Nitta K
    J Am Soc Nephrol; 2019 Feb; 30(2):261-276. PubMed ID: 30635373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J; Dai C; Liu Y
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model.
    Chen HA; Chen CM; Guan SS; Chiang CK; Wu CT; Liu SH
    Phytomedicine; 2019 Jun; 59():152917. PubMed ID: 30978648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy.
    Rampanelli E; Rouschop K; Teske GJ; Claessen N; Leemans JC; Florquin S
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1445-54. PubMed ID: 24026183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatocyte growth factor-transfected bone marrow-derived mesenchymal stem cells towards renal fibrosis in rats.
    Xie M; Wan J; Zhang F; Zhang R; Zhou Z; You D
    Indian J Med Res; 2019 Apr; 149(4):508-516. PubMed ID: 31411175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
    Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
    Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid attenuates kidney fibrosis via antifibrotic action of BMP-7 and HGF.
    Yunus J; Salman M; Lintin GBR; Muchtar M; Sari DCR; Arfian N; Romi MM
    Med J Malaysia; 2020 May; 75(Suppl 1):5-9. PubMed ID: 32471962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Growth Factor in Predialysis and Hemodialysis Chronic Kidney Disease Patients.
    Vulugundam SC; Kiranmayi VS; Rao PVLNS; Vishnubhotla SK
    Saudi J Kidney Dis Transpl; 2022; 33(1):58-65. PubMed ID: 36647979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.
    Gao X; Mae H; Ayabe N; Takai T; Oshima K; Hattori M; Ueki T; Fujimoto J; Tanizawa T
    Kidney Int; 2002 Oct; 62(4):1238-48. PubMed ID: 12234294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.
    Bai M; Lei J; Wang S; Ding D; Yu X; Guo Y; Chen S; Du Y; Li D; Zhang Y; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1430-F1438. PubMed ID: 31545926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft nephropathy in rats is improved by the intervention of rhein.
    Su J; Yin LP; Zhang X; Li BB; Liu L; Li H
    Transplant Proc; 2013; 45(6):2546-52. PubMed ID: 23953579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice.
    Kagawa T; Takemura G; Kosai K; Murata I; Ohno T; Takahashi T; Esaki M; Maruyama R; Fujiwara T; Ohashi H; Fujiwara H
    Nephron Physiol; 2006; 102(3-4):p92-102. PubMed ID: 16340242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
    Andrikopoulos P; Kieswich J; Pacheco S; Nadarajah L; Harwood SM; O'Riordan CE; Thiemermann C; Yaqoob MM
    J Am Soc Nephrol; 2019 Jan; 30(1):33-49. PubMed ID: 30530834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.
    Cao J; Wang W; Li Y; Xia J; Peng Y; Zhang Y; Xia A
    Int Urol Nephrol; 2016 Apr; 48(4):619-29. PubMed ID: 26865179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.
    Dai C; Yang J; Bastacky S; Xia J; Li Y; Liu Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice.
    Dai C; Yang J; Liu Y
    J Am Soc Nephrol; 2002 Feb; 13(2):411-422. PubMed ID: 11805170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor exerts beneficial effects on mice with type II diabetes‑induced chronic renal failure via the NF‑κB pathway.
    Cheng G; Tang X; Zhang J
    Mol Med Rep; 2018 Sep; 18(3):3389-3396. PubMed ID: 30066918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease.
    Zeisberg M; Kalluri R
    Pediatr Nephrol; 2008 Sep; 23(9):1395-8. PubMed ID: 18446379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.